0       0


ST4-24: Graft Engineering for Cell-Based Therapies: Before and Beyond CAR T Cells


Oct 19, 2019 1:30pm ‐ Oct 19, 2019 3:00pm

Description

Spanish Captions Available

Ingeniería de Injerto en terapia Celular: Antes y Más Allá de las Células T con Receptor de Antígeno Quimérico

Concurrent with recent success using gene-modified T cells for immunotherapy, is exciting progress in the refinement, scale-up and clinical applications of non-gene modified immune effector cells. The speakers in this session will provide state-of-the-art reviews of laboratory methodologies, manufacturing and production challenges, clinical data and the therapeutic potential of autologous and allogeneic natural killer (NK) cells, dendritic cells (DC) and T cells to treat malignant diseases.

At the completion of this session, participants should be able to:

  • Appreciate the therapeutic potential of non-gene modified immune effector cells for the treatment of malignant diseases.
  • Identify the technical challenges and methodologies to optimize immune cell populations for adoptive immunotherapy.
  • Recognize the future directions and opportunities for broader applications of cell-based immunotherapies.

Speaker(s):

You must be logged in and own this session in order to post comments.

Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content